Measured Wealth Private Client Group, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 1 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Measured Wealth Private Client Group, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$8,000
-55.6%
38,1160.0%0.01%
-50.0%
Q2 2019$18,000
+5.9%
38,1160.0%0.01%0.0%
Q1 2019$17,00038,1160.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,500,000$1,817,0000.46%
Fosun International Ltd 2,631,400$1,881,0000.09%
Zhang Financial LLC 45,000$34,0000.02%
SECTORAL ASSET MANAGEMENT INC 99,667$72,0000.01%
ETF MANAGERS GROUP, LLC 331,521$221,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,064$91,0000.00%
B. Riley Wealth Management, Inc. 18,329$13,0000.00%
Virtu Financial LLC 63,626$46,0000.00%
Renaissance Technologies 3,266,401$2,374,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 214,938$156,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders